Company profile
Acceleron Pharma company profile
Acceleron Pharma, Inc. operates as a biopharmaceutical company. The company engages in developing, manufacturing, and commercializing novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases. Its products include ACE-011 Program, a novel bone forming agent that helps to treat cancer-related bone loss; ACE-031 Program that helps to treat diseases involving the loss of muscle mass, strength, and function in diseases, including muscular dystrophy, amyotrophic lateral sclerosis, and cancer-related muscle loss; and ACE-041, a protein therapeutic that binds a member of the growth and differentiation factor family necessary for angiogenesis...... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://acceleronpharma.com/
- Contact email
- [email protected]
- Phone number
- 617-649-9200
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00101-00250 employees
- Revenue range
- $50K+
- Founded
- 2004-01-01
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Postal code
- 02139
- Country code
- US
- Continent
- North America